Login / Signup
Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment.
Paulo Roberto Barbosa Évora
Published in:
Critical care (London, England) (2018)
Keyphrases
</>
nitric oxide
protein kinase
combination therapy